HK Stock MarketDetailed Quotes

DAWNRAYS PHARMA (02348)

Watchlist
  • 1.130
  • +0.010+0.89%
Noon Break May 14 10:52 CST
1.70BMarket Cap7.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DAWNRAYS PHARMA (02348) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
16.09%1.23B
9.17%630.42M
-7.89%1.06B
-11.15%577.45M
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
Operating income
16.09%1.23B
9.17%630.42M
-7.89%1.06B
-11.15%577.45M
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
Cost of sales
-28.18%-618.72M
-32.11%-316.45M
5.29%-482.68M
16.85%-239.54M
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
Operating expenses
-28.18%-618.72M
-32.11%-316.45M
5.29%-482.68M
16.85%-239.54M
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
Gross profit
5.98%612.15M
-7.08%313.98M
-9.96%577.63M
-6.62%337.91M
-17.07%641.52M
-7.76%361.85M
13.55%773.55M
5.14%392.28M
23.72%681.26M
40.93%373.09M
Selling expenses
17.08%-106M
17.53%-56.83M
13.07%-127.84M
0.13%-68.91M
-3.02%-147.05M
12.58%-69M
-30.91%-142.73M
-9.23%-78.93M
-99.79%-109.03M
-83.06%-72.26M
Administrative expenses
-6.07%-138.28M
-24.64%-67.49M
-15.16%-130.37M
8.50%-54.15M
7.25%-113.21M
-9.20%-59.18M
-3.96%-122.06M
-0.85%-54.2M
-7.49%-117.41M
-6.87%-53.74M
Research and development expenses
-17.86%-83.48M
-29.47%-56.82M
22.00%-70.83M
-42.66%-43.88M
-14.26%-90.81M
-2.67%-30.76M
-18.57%-79.48M
-6.45%-29.96M
-15.68%-67.03M
-22.52%-28.15M
Operating interest expense
----
----
----
----
----
----
----
-46.10%-225K
86.72%-641K
---154K
Special items of operating profit
-108.67%-34.29M
-100.56%-2.21M
139.04%395.66M
170.57%392.14M
131.82%165.52M
746.72%144.93M
-27.57%71.4M
81.90%17.12M
279.30%98.59M
-59.82%9.41M
Operating profit
-61.18%250.11M
-76.80%130.63M
41.29%644.25M
61.89%563.11M
-8.93%455.98M
41.35%347.84M
3.08%500.68M
7.84%246.08M
38.76%485.74M
30.09%228.2M
Financing cost
86.25%-496K
88.20%-314K
-264.81%-3.61M
-698.80%-2.66M
-166.58%-989K
---333K
---371K
----
----
----
Share of profits of associates
----
----
90.97%-3.7M
81.79%-3.7M
33.88%-40.93M
0.95%-20.3M
-33.36%-61.91M
-19.69%-20.49M
-147.29%-46.42M
-71.91%-17.12M
Earning before tax
-60.81%249.61M
-76.59%130.32M
53.83%636.95M
70.15%556.75M
-5.55%414.06M
45.05%327.21M
-0.21%438.41M
6.87%225.59M
32.61%439.32M
30.37%211.08M
Tax
48.10%-38.51M
56.10%-28.61M
18.82%-74.19M
10.78%-65.17M
-10.70%-91.39M
-35.85%-73.04M
3.06%-82.56M
-18.45%-53.77M
-28.05%-85.16M
-32.13%-45.39M
After-tax profit from continuing operations
-62.49%211.11M
-79.31%101.71M
74.41%562.76M
93.41%491.58M
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
Earning after tax
-62.49%211.11M
-79.31%101.71M
74.41%562.76M
93.41%491.58M
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
Minority profit
-31.50%-2.86M
-95.76%-2.86M
34.65%-2.18M
17.39%-1.46M
-51.09%-3.33M
-1,173.33%-1.77M
45.01%-2.21M
117.28%165K
-20.23%-4.01M
55.35%-955K
Profit attributable to shareholders
-62.13%213.97M
-78.79%104.57M
73.29%564.94M
92.64%493.05M
-8.95%326M
49.10%255.94M
-0.03%358.06M
3.01%171.66M
33.58%358.18M
28.49%166.65M
Basic earnings per share
-63.16%0.14
-78.82%0.0696
74.79%0.38
92.50%0.3286
-9.00%0.2174
48.95%0.1707
-0.13%0.2389
2.96%0.1146
37.79%0.2392
33.13%0.1113
Diluted earnings per share
-63.16%0.14
-78.79%0.0696
75.12%0.38
92.83%0.3282
-8.94%0.217
48.91%0.1702
0.34%0.2383
3.07%0.1143
36.89%0.2375
32.66%0.1109
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 16.09%1.23B9.17%630.42M-7.89%1.06B-11.15%577.45M-9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M
Operating income 16.09%1.23B9.17%630.42M-7.89%1.06B-11.15%577.45M-9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M
Cost of sales -28.18%-618.72M-32.11%-316.45M5.29%-482.68M16.85%-239.54M-1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M
Operating expenses -28.18%-618.72M-32.11%-316.45M5.29%-482.68M16.85%-239.54M-1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M
Gross profit 5.98%612.15M-7.08%313.98M-9.96%577.63M-6.62%337.91M-17.07%641.52M-7.76%361.85M13.55%773.55M5.14%392.28M23.72%681.26M40.93%373.09M
Selling expenses 17.08%-106M17.53%-56.83M13.07%-127.84M0.13%-68.91M-3.02%-147.05M12.58%-69M-30.91%-142.73M-9.23%-78.93M-99.79%-109.03M-83.06%-72.26M
Administrative expenses -6.07%-138.28M-24.64%-67.49M-15.16%-130.37M8.50%-54.15M7.25%-113.21M-9.20%-59.18M-3.96%-122.06M-0.85%-54.2M-7.49%-117.41M-6.87%-53.74M
Research and development expenses -17.86%-83.48M-29.47%-56.82M22.00%-70.83M-42.66%-43.88M-14.26%-90.81M-2.67%-30.76M-18.57%-79.48M-6.45%-29.96M-15.68%-67.03M-22.52%-28.15M
Operating interest expense -----------------------------46.10%-225K86.72%-641K---154K
Special items of operating profit -108.67%-34.29M-100.56%-2.21M139.04%395.66M170.57%392.14M131.82%165.52M746.72%144.93M-27.57%71.4M81.90%17.12M279.30%98.59M-59.82%9.41M
Operating profit -61.18%250.11M-76.80%130.63M41.29%644.25M61.89%563.11M-8.93%455.98M41.35%347.84M3.08%500.68M7.84%246.08M38.76%485.74M30.09%228.2M
Financing cost 86.25%-496K88.20%-314K-264.81%-3.61M-698.80%-2.66M-166.58%-989K---333K---371K------------
Share of profits of associates --------90.97%-3.7M81.79%-3.7M33.88%-40.93M0.95%-20.3M-33.36%-61.91M-19.69%-20.49M-147.29%-46.42M-71.91%-17.12M
Earning before tax -60.81%249.61M-76.59%130.32M53.83%636.95M70.15%556.75M-5.55%414.06M45.05%327.21M-0.21%438.41M6.87%225.59M32.61%439.32M30.37%211.08M
Tax 48.10%-38.51M56.10%-28.61M18.82%-74.19M10.78%-65.17M-10.70%-91.39M-35.85%-73.04M3.06%-82.56M-18.45%-53.77M-28.05%-85.16M-32.13%-45.39M
After-tax profit from continuing operations -62.49%211.11M-79.31%101.71M74.41%562.76M93.41%491.58M-9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M
Earning after tax -62.49%211.11M-79.31%101.71M74.41%562.76M93.41%491.58M-9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M
Minority profit -31.50%-2.86M-95.76%-2.86M34.65%-2.18M17.39%-1.46M-51.09%-3.33M-1,173.33%-1.77M45.01%-2.21M117.28%165K-20.23%-4.01M55.35%-955K
Profit attributable to shareholders -62.13%213.97M-78.79%104.57M73.29%564.94M92.64%493.05M-8.95%326M49.10%255.94M-0.03%358.06M3.01%171.66M33.58%358.18M28.49%166.65M
Basic earnings per share -63.16%0.14-78.82%0.069674.79%0.3892.50%0.3286-9.00%0.217448.95%0.1707-0.13%0.23892.96%0.114637.79%0.239233.13%0.1113
Diluted earnings per share -63.16%0.14-78.79%0.069675.12%0.3892.83%0.3282-8.94%0.21748.91%0.17020.34%0.23833.07%0.114336.89%0.237532.66%0.1109
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +4.21%
Sample Name
Sample Code
 +2.55%
Sample Name
Sample Code
 +2.36%
4
SINOPEC CORP
00386
+1.10%
5
CNOOC
00883
+0.84%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +41.30%
Sample Name
Sample Code
 +31.64%
4
Loongson Technology Corporation
688047
+21.03%
5
Digital China Group
000034
+16.67%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -